| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Hong Chen | Q96249488 |
| P2093 | author name string | Hao Wu | |
| Diane R Bielenberg | |||
| Kai Song | |||
| Scott Wong | |||
| Yunzhou Dong | |||
| Aiyun Wen | |||
| H N Ashiqur Rahman | |||
| Megan L Brophy | |||
| Sukyoung Kwak | |||
| P2860 | cites work | Modes of resistance to anti-angiogenic therapy | Q24608005 |
| Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting | Q24685542 | ||
| Molecular control of endothelial cell behaviour during blood vessel morphogenesis | Q27007664 | ||
| Therapeutic antibody targeting of individual Notch receptors | Q27660544 | ||
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| Epsins: adaptors in endocytosis? | Q27939888 | ||
| Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis | Q28115833 | ||
| Epsin Family of Endocytic Adaptor Proteins as Oncogenic Regulators of Cancer Progression | Q28307353 | ||
| Selective high-level expression of epsin 3 in gastric parietal cells, where it is localized at endocytic sites of apical canaliculi | Q28511738 | ||
| The epsins define a family of proteins that interact with components of the clathrin coat and contain a new protein module | Q28566047 | ||
| Spatial regulation of VEGF receptor endocytosis in angiogenesis | Q28585752 | ||
| Embryonic arrest at midgestation and disruption of Notch signaling produced by the absence of both epsin 1 and epsin 2 in mice | Q28586389 | ||
| Epsin potentiates Notch pathway activity in Drosophila and C. elegans | Q47071284 | ||
| Developmental selection of var gene expression in Plasmodium falciparum | Q47741507 | ||
| VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis | Q50730548 | ||
| Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. | Q52855186 | ||
| Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling | Q28587298 | ||
| Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
| Signals for sorting of transmembrane proteins to endosomes and lysosomes | Q29547469 | ||
| A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins | Q29616733 | ||
| Notch signaling is essential for vascular morphogenesis in mice | Q29620377 | ||
| Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer | Q29622818 | ||
| Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation | Q30167778 | ||
| Normalization of the vasculature for treatment of cancer and other diseases | Q30471456 | ||
| Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels | Q33592643 | ||
| An inside view: VEGF receptor trafficking and signaling | Q33682832 | ||
| The association of epsin with ubiquitinated cargo along the endocytic pathway is negatively regulated by its interaction with clathrin | Q33864158 | ||
| Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs | Q33897492 | ||
| A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems | Q33951379 | ||
| Sunitinib malate for the treatment of pancreatic neuroendocrine tumors | Q34163515 | ||
| Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits | Q34164071 | ||
| Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development | Q34471536 | ||
| Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function | Q34483937 | ||
| Tissue-penetrating delivery of compounds and nanoparticles into tumors | Q35016106 | ||
| VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors | Q35064894 | ||
| Sorting it out: AP-2 and alternate clathrin adaptors in endocytic cargo selection | Q35569243 | ||
| Motif mimetic of epsin perturbs tumor growth and metastasis | Q36335923 | ||
| Lessons from phase III clinical trials on anti-VEGF therapy for cancer | Q36366446 | ||
| VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2 | Q36419140 | ||
| Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling | Q36498075 | ||
| A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis | Q36949613 | ||
| Pathways mediating resistance to vascular endothelial growth factor-targeted therapy | Q37300871 | ||
| Angiogenesis: a team effort coordinated by notch. | Q37393190 | ||
| Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. | Q37594746 | ||
| Tumor angiogenesis: molecular pathways and therapeutic targets | Q37953773 | ||
| Forty-year journey of angiogenesis translational research | Q37970646 | ||
| Endosomal crosstalk: meeting points for signaling pathways. | Q38026339 | ||
| Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis. | Q39185970 | ||
| Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. | Q39186300 | ||
| Endocytic adaptor protein epsin is elevated in prostate cancer and required for cancer progression | Q39415229 | ||
| Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis | Q40191484 | ||
| Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis | Q40191493 | ||
| Are epsins a therapeutic target for tumor angiogenesis? | Q41844357 | ||
| Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency | Q41945502 | ||
| Angiogenesis: A happy medium? | Q43660164 | ||
| Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells | Q44370252 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 393-398 | |
| P577 | publication date | 2016-08-29 | |
| P1433 | published in | Cellular and Molecular Life Sciences | Q5058352 |
| P1476 | title | Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis | |
| P478 | volume | 74 |
| Q96431012 | A self-sustaining endocytic-based loop promotes breast cancer plasticity leading to aggressiveness and pro-metastatic behavior |
| Q37706572 | Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation |
| Q47138631 | Overlapping Mechanisms of Peripheral Nerve Regeneration and Angiogenesis Following Sciatic Nerve Transection |
Search more.